scholarly journals Beta-amyloid PET imaging for Alzheimer's dementia diagnosis

2018 ◽  
Vol 22 (4) ◽  
pp. 31-35
Author(s):  
Andrew Byrne ◽  
James Prichard
Keyword(s):  
Pet Imaging ◽  
Beta Amyloid ◽  
Alzheimer’S Dementia ◽  
Amyloid Pet ◽  
Dementia Diagnosis ◽  
Alzheimer's Dementia ◽  
Amyloid Pet Imaging

scholarly journals PMD51 Cost Savings and Improved Utility through the Use of Florbetaben Beta-Amyloid PET Imaging in Dementia Diagnosis

2011 ◽  
Vol 14 (7) ◽  
pp. A253 ◽  
Author(s):  
R. Pastätter ◽  
K. Uhl-hochgräber ◽  
M. Blankenburg
Keyword(s):  
Pet Imaging ◽  
Cost Savings ◽  
Beta Amyloid ◽  
Amyloid Pet ◽  
Dementia Diagnosis ◽  
Amyloid Pet Imaging

scholarly journals P1-299: Multicenter phase II trial of florbetaben beta-amyloid PET imaging in Alzheimer's disease: Results in a close to clinically routine situation

2013 ◽  
Vol 9 ◽  
pp. P264-P264
Author(s):  
Osama Sabri ◽  
John Seibyl ◽  
Keiichi Ischihara ◽  
Amane Tateno ◽  
Alexander Drzezga ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Phase Ii ◽  
Pet Imaging ◽  
Phase Ii Trial ◽  
Beta Amyloid ◽  
Amyloid Pet ◽  
Multicenter Phase ◽  
Routine Situation ◽  
Amyloid Pet Imaging

scholarly journals IC-P-002: Atrophy correction enhances the diagnostic performance of florbetaben beta-amyloid PET imaging

2013 ◽  
Vol 9 ◽  
pp. P11-P11
Author(s):  
Henryk Barthel ◽  
Michael Rullmann ◽  
Jürgen Dukart ◽  
Stefanie Herbert ◽  
Julia Luthardt ◽  
...  
Keyword(s):  
Pet Imaging ◽  
Diagnostic Performance ◽  
Beta Amyloid ◽  
Amyloid Pet ◽  
Amyloid Pet Imaging

P2-325: AMYLOID PET IMAGING IN A COMMUNITY NEUROLOGY PRACTICE: FEASIBILITY AND CLINICAL OUTCOMES

2006 ◽  
Vol 14 (7S_Part_15) ◽  
pp. P807-P807
Author(s):  
Michael H. Rosenbloom ◽  
Kathryn A. Wyman-Chick ◽  
Lauren O. Erickson ◽  
Paul Carolan ◽  
Joshua Johnson ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Pet Imaging ◽  
Amyloid Pet ◽  
Amyloid Pet Imaging

scholarly journals Amyloid PET imaging: a challenge for research in clinical neuroimaging

2015 ◽  
Vol 3 (1) ◽  
pp. 3-5
Author(s):  
Kirk Frey ◽  
Daniela Perani
Keyword(s):  
Pet Imaging ◽  
Amyloid Pet ◽  
Amyloid Pet Imaging

scholarly journals Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging

2018 ◽  
Vol 32 (1) ◽  
pp. 35-42 ◽  
Author(s):  
Rafid Mustafa ◽  
Jared R. Brosch ◽  
Gil D. Rabinovici ◽  
Bradford C. Dickerson ◽  
Maria C. Carrillo ◽  
...  
Keyword(s):  
Pet Imaging ◽  
Amyloid Pet ◽  
Clinical Use ◽  
Amyloid Pet Imaging

scholarly journals A Review of Diagnostic Impact of Amyloid Positron Emission Tomography Imaging in Clinical Practice

2018 ◽  
Vol 46 (3-4) ◽  
pp. 154-167 ◽  
Author(s):  
Yejin Kim ◽  
Paul Rosenberg ◽  
Esther Oh
Keyword(s):  
Positron Emission Tomography ◽  
Clinical Practice ◽  
Pet Imaging ◽  
Clinical Utility ◽  
Patient Management ◽  
Emission Tomography ◽  
Amyloid Pet ◽  
Diagnostic Confidence ◽  
Positron Emission ◽  
Amyloid Pet Imaging

Background: Molecular imaging of brain amyloid for the diagnosis of Alzheimer’s disease (AD) using positron emission tomography (PET) has been approved for use in clinical practice by the Food and Drug Administration (FDA) since 2012. However, the clinical utility and diagnostic impact of amyloid PET imaging remain controversial. We conducted a review of the recent studies investigating clinical utility of amyloid PET imaging with focus on changes in diagnosis, diagnostic confidence, and patient management. Summary: A total of 16 studies were included in the final analysis. Overall rate of changes in diagnosis after amyloid PET ranged from 9 to 68% (pooled estimate of 31%, 95% CI 23–39%). All studies reported overall increase in diagnostic confidence or diagnostic certainty after amyloid PET. Changes in patient management ranged from 37 to 87%; the most common type of change in management reported was either the initiation or discontinuation of planned AD medications. Key Messages: Amyloid PET imaging led to moderate to significant changes in diagnosis, diagnostic confidence, and subsequent patient management. It may be most useful in patients with high level of diagnostic uncertainty even after the completing the standard workup.

Sign in / Sign up

Export Citation Format

Share Document